All Programs

Use the tool below to view all available Global Neurology Academy Series

Prioritizing Patient-Centered, Multidisciplinary Care in CIDP
Prioritizing Patient-Centered, Multidisciplinary Care in CIDP
Global Neurology Academy
Prioritizing Patient-Centered, Multidisciplinary Care in CIDP
- Andrew G. Lee, MD
- Ashley Baker, MSN, PMHNP
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
NeuroFrontiers
Gene Therapy Safety in DMD: How to Identify Common Immune Reactions
- Kaitlin Batley, MD
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
NeuroFrontiers
Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
- Christopher A. Scheiner, MD, PhD
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
NeuroFrontiers
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
Managing MS in Older Adults: Top 5 Clinical Considerations
Managing MS in Older Adults: Top 5 Clinical Considerations
NeuroFrontiers
Managing MS in Older Adults: Top 5 Clinical Considerations
- Yinan Zhang, MD
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
Global Neurology Academy
New Frontiers in CIDP Care: Exploring Approved and Emerging Therapies
- Chafic Karam, MD
- Ryan Quigley
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
Global Neurology Academy
Empowering Patients with CIDP: Education, Support, and Personalized Care Strategies
- Danielle Minetti
- Ryan Quigley
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
CME/CE
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
1.00 credit
- Alejandro A. Rabinstein, MD, FAHA
- Richard E. Pratley, MD
- Jay H. Shubrook, DO, FACOFP, FAAFP
1.00 credit
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
NeuroFrontiers
Updates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
- Richard Nowak, MD, MS
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
NeuroFrontiers
How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
- John A. Morren, MD, FAAN, FAANEM
CME/CE Meeting
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
July 30, 2025
Toronto
Learn more
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
NeuroFrontiers
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
NeuroFrontiers
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
- Maxwell H. Levy, MD
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
NeuroFrontiers
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
- Rosaline Quinlivan
- Ryan Quigley
New Frontiers in the Treatment of DMD Across the Age Spectrum
New Frontiers in the Treatment of DMD Across the Age Spectrum
CME/CE
New Frontiers in the Treatment of DMD Across the Age Spectrum
1.00 credit
- Crystal Proud, MD
- John Brandsema, MD
- Omer Abdul Hamid, MD
1.00 credit
Reducing the Burden of gMG with a Novel B-Cell Therapy
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiers
Reducing the Burden of gMG with a Novel B-Cell Therapy
- Richard Nowak, MD, MS

All Programs

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

All Programs

Popular

Title

Share on ReachMD